arrow
A

Anders Björklund

University of Cambridge
H指数:159
被引数:8.2万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

STEM-PD trial protocol: a multi-centre, single-arm, first-in-human, dose-escalation trial, investigating the safety and tolerability of intraputamenal transplantation of human embryonic stem cell-derived dopaminergic cells for Parkinson's disease

STEM-PD试验方案:一项多中心、单臂、首个人类、剂量递增试验,旨在研究向豆状核内移植人胚胎干细胞来源的多巴胺能细胞治疗帕金森病的安全性和耐受性。

2025-12-300
OA
The TransEuro open-label trial of human fetal ventral mesencephalic transplantation in patients with moderate Parkinson's disease

TransEuro开放标签试验:人类胎儿腹侧中脑移植治疗中度帕金森病患者的临床研究

2025-05-020
OA
TARGET- seq: Linking single- cell transcriptomics of human dopaminergic neurons with their target specificity

Target-seq: 将人多巴胺能神经元的单细胞转录组学与其靶特异性联系起来

2024-11-140
OAAI
Preclinical quality, safety, and efficacy of a human embryonic stem cell-derived product for the treatment of Parkinson's disease, STEM-PD
2023-10-0131
OA
Grafts Derived from an α-Synuclein Triplication Patient Mediate Functional Recovery but Develop Disease-Associated Pathology in the 6-OHDA Model of Parkinson's Disease

源自 α-突触核蛋白三倍体患者的移植物介导功能恢复,但在帕金森氏病的6-OHDA模型中发展与疾病相关的病理

2021-04-137
OAAI
GDNF and Parkinson's Disease: Where Next? A Summary from a Recent Workshop
2020-07-2883
OAAI
Impact of α-synuclein pathology on transplanted hESC-derived dopaminergic neurons in a humanized α-synuclein rat model of PD

人源化 α-突触核蛋白PD大鼠模型中 α-突触核蛋白病理学对移植的hESC衍生的多巴胺能神经元的影响

2020-06-1545
OAAI